Recruitment and Retention Strategies for the Diabetes RElated to Acute Pancreatitis and Its Mechanisms Study: From the Type 1 Diabetes in Acute Pancreatitis Consortium.
Journal
Pancreas
ISSN: 1536-4828
Titre abrégé: Pancreas
Pays: United States
ID NLM: 8608542
Informations de publication
Date de publication:
01 07 2022
01 07 2022
Historique:
entrez:
7
10
2022
pubmed:
8
10
2022
medline:
12
10
2022
Statut:
ppublish
Résumé
Recruitment and retention of patients with acute pancreatitis (AP) in clinical studies can be challenging. While some obstacles are similar to other clinical conditions, some are unique to AP. Identifying potential barriers early and developing targeted solutions can help optimize recruitment and retention in AP studies. Such pre-emptive and detailed planning can help prospective, longitudinal studies focus on exocrine and endocrine complications of AP in accurately measuring outcomes. This article highlights the challenges in recruitment and retention strategies in AP studies and reviews available resources to create opportunities to address them. We describe the multifaceted approach used by the Recruitment and Retention Committee of the Type 1 Diabetes in Acute Pancreatitis Consortium, which builds upon earlier experiences to develop a recruitment and retention plan for the DREAM (Diabetes RElated to Acute pancreatitis and its Mechanisms) study.
Identifiants
pubmed: 36206465
doi: 10.1097/MPA.0000000000002072
pii: 00006676-202207000-00007
pmc: PMC9555856
mid: NIHMS1817020
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
598-603Subventions
Organisme : NCATS NIH HHS
ID : KL2 TR002002
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK127403
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK127392
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK127367
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK127395
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK127388
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK127377
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK127382
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK127400
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK127378
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK127404
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK127384
Pays : United States
Informations de copyright
Copyright © 2022 Written work prepared by employees of the Federal Government as part of their official duties is, under the U.S. Copyright Act, a “work of the United States Government” for which copyright protection under Title 17 of the United States Code is not available. As such, copyright does not extend to the contributions of employees of the Federal Government.
Déclaration de conflit d'intérêts
E.A. is part of advisory board for Nestle. M.D.B. receives research support from Viacyte and Dexcom and is part of advisory board for Insulet. AC is part of advisory board for GSK and expert opinion for Guidepoint. P.J.L. is part of advisory board for AbbVie. G.I.P. receives research support from AbbVie, has consulting activities with Olympus and Nestle, and receives equity with Ariel Precision Medicine. The other authors declare no conflict of interest.
Références
Krishna SG, Kamboj AK, Hart PA, et al. The changing epidemiology of acute pancreatitis hospitalizations: a decade of trends and the impact of chronic pancreatitis. Pancreas . 2017;46:482–488.
Das SL, Singh PP, Phillips AR, et al. Newly diagnosed diabetes mellitus after acute pancreatitis: a systematic review and meta-analysis. Gut . 2014;63:818–831.
Shen HN, Yang CC, Chang YH, et al. Risk of diabetes mellitus after first-attack acute pancreatitis: a national population-based study. Am J Gastroenterol . 2015;110:1698–1706.
Zhi M, Zhu X, Lugea A, et al. Incidence of new onset diabetes mellitus secondary to acute pancreatitis: a systematic review and meta-analysis. Front Physiol . 2019;10:637.
Carlisle B, Kimmelman J, Ramsay T, et al. Unsuccessful trial accrual and human subjects protections: an empirical analysis of recently closed trials. Clin Trials . 2015;12:77–83.
Nipp RD, Hong K, Paskett ED. Overcoming barriers to clinical trial enrollment. Am Soc Clin Oncol Educ Book . 2019;39:105–114.
Rodríguez-Torres E, González-Pérez MM, Díaz-Pérez C. Barriers and facilitators to the participation of subjects in clinical trials: an overview of reviews. Contemp Clin Trials Commun . 2021;23:100829.
Afghani E, Pandol SJ, Shimosegawa T, et al. Acute pancreatitis-progress and challenges: a report on an international symposium. Pancreas . 2015;44:1195–1210.
Uc A, Andersen DK, Borowitz D, et al. Accelerating the drug delivery pipeline for acute and chronic pancreatitis-knowledge gaps and research opportunities: overview summary of a National Institute of Diabetes and Digestive and Kidney Diseases workshop. Pancreas . 2018;47:1180–1184.
Elmunzer BJ, Serrano J, Chak A, et al. Rectal indomethacin alone versus indomethacin and prophylactic pancreatic stent placement for preventing pancreatitis after ERCP: study protocol for a randomized controlled trial. Trials . 2016;17:120.
Coté GA, Durkalski-Mauldin VL, Serrano J, et al. SpHincterotomy for Acute Recurrent Pancreatitis randomized trial: rationale, methodology, and potential implications. Pancreas . 2019;48:1061–1067.
Yadav D, Park WG, Fogel EL, et al. PROspective evaluation of Chronic pancreatitis for EpidEmiologic and translational stuDies: rationale and study design for PROCEED from the consortium for the study of chronic pancreatitis, diabetes, and pancreatic Cancer. Pancreas . 2018;47:1229–1238.
Paragomi P, Phillips AE, Machicado JD, et al. Post-acute pancreatitis pancreatic exocrine insufficiency: rationale and methodology of a prospective, observational, multicenter cohort study. Pancreas . 2021;50:147–152.
Márta K, Szabó AN, Pécsi D, et al. High versus low energy administration in the early phase of acute pancreatitis (GOULASH trial): protocol of a multicentre randomised double-blind clinical trial. BMJ Open . 2017;7:e015874.
Bharmal SH, Cho J, Alarcon Ramos GC, et al. Trajectories of glycaemia following acute pancreatitis: a prospective longitudinal cohort study with 24 months follow-up. J Gastroenterol . 2020;55:775–788.
Wilkins CH, Edwards TL, Stroud M, et al. The recruitment innovation center: developing novel, person-centered strategies for clinical trial recruitment and retention. J Clin Transl Sci . 2021;5:e194.
Shah MR, Culp MA, Gersing KR, et al. Early vision for the CTSA program trial innovation network: a perspective from the National Center for Advancing Translational Sciences. Clin Transl Sci . 2017;10:311–313.
Cervantes A, Waymouth EK, Petrov MS. African-Americans and indigenous peoples have increased burden of diseases of the exocrine pancreas: a systematic review and meta-analysis. Dig Dis Sci . 2019;64:249–261.
Frey CF, Zhou H, Harvey DJ, et al. The incidence and case-fatality rates of acute biliary, alcoholic, and idiopathic pancreatitis in California, 1994–2001. Pancreas . 2006;33:336–344.
Wu BU, Banks PA, Conwell DL. Disparities in emergency department wait times for acute gastrointestinal illnesses: results from the National Hospital Ambulatory Medical Care Survey, 1997–2006. Am J Gastroenterol . 2009;104:1668–1673.